CIK 0001035354 · Non-accelerated filer<br>Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841368850
- Phone
- 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- DEF 14A Proxy Proxy Statement
- 8-K Event Results of operations
- 10KSB Other 10KSB
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- 4 Insider Changes in Ownership
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- REGDEX Other REGDEX
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Results of operations
- 10QSB Other 10QSB
- 8-K Event Unregistered share sale · Other events
- 8-K Event Material agreement
Page 61 of 68 · 1,360 filings